We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
Cap. Flow
+$1.28B
Cap. Flow %
3.53%
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$34.8M
2
AAPL icon
Apple
AAPL
+$33.7M
3
XOM icon
ExxonMobil
XOM
+$30M
4
MSFT icon
Microsoft
MSFT
+$25.3M
5
FTV icon
Fortive
FTV
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Financials 14.59%
3 Healthcare 13.89%
4 Industrials 10.54%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNM
2801
DELISTED
FANNIE MAE
FNM
$107K ﹤0.01%
63,500
VNCE icon
2802
Vince Holding Corp
VNCE
$81.3M
$105K ﹤0.01%
1,854
+21
+1% +$1.19K
FRE
2803
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$104K ﹤0.01%
66,008
ADVM
2804
DELISTED
Adverum Biotechnologies
ADVM
$102K ﹤0.01%
2,477
+50
+2% +$1.9K
VCYT icon
2805
Veracyte
VCYT
$3.7B
$100K ﹤0.01%
13,143
+140
+1% +$792
GIG
2806
DELISTED
GigPeak, Inc.
GIG
$100K ﹤0.01%
42,413
+8,500
+25% +$17.6K
MN
2807
DELISTED
MANNING & NAPIER, INC.
MN
$99K ﹤0.01%
13,983
+2,200
+19% +$17.6K
CLD
2808
DELISTED
Cloud Peak Energy Inc
CLD
$99K ﹤0.01%
18,145
-9,615
-35% -$33.4K
WG
2809
DELISTED
Willbros Group
WG
$99K ﹤0.01%
52,402
+3,500
+7% +$7.18K
ASXC
2810
DELISTED
Asensus Surgical, Inc.
ASXC
$98K ﹤0.01%
4,472
+146
+3% +$2.67K
MOBL
2811
DELISTED
MobileIron, Inc.
MOBL
$98K ﹤0.01%
35,808
+700
+2% +$2.16K
OSIR
2812
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$97K ﹤0.01%
19,569
MFIC icon
2813
MidCap Financial Investment
MFIC
$787M
$96K ﹤0.01%
5,509
+29
+0.5% +$508
DMTX
2814
DELISTED
Dimension Therapeutics, Inc
DMTX
$94K ﹤0.01%
+11,775
New +$85.1K
SALM
2815
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$93K ﹤0.01%
15,840
+2,900
+22% +$19.6K
GNE icon
2816
Genie Energy
GNE
$367M
$91K ﹤0.01%
15,480
+40
+0.3% +$257
OCUL icon
2817
Ocular Therapeutix
OCUL
$1.79B
$91K ﹤0.01%
13,284
+230
+2% +$1.4K
GWRS icon
2818
Global Water Resources
GWRS
$206M
$89K ﹤0.01%
11,140
+1,100
+11% +$9.07K
SYUT
2819
DELISTED
Synutra International, Inc.
SYUT
$89K ﹤0.01%
20,890
+3,400
+19% +$12.8K
PMTS icon
2820
CPI Card Group
PMTS
$242M
$88K ﹤0.01%
2,925
+100
+4% +$2.58K
MRTX
2821
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$87K ﹤0.01%
13,087
+100
+0.8% +$532
I
2822
DELISTED
INTELSAT S. A.
I
$87K ﹤0.01%
32,041
-5,950
-16% -$16.1K
WKHS icon
2823
Workhorse Group
WKHS
$33.2M
$85K ﹤0.01%
4
III icon
2824
Information Services Group
III
$199M
$84K ﹤0.01%
20,944
+7,200
+52% +$27.9K
UDF
2825
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$84K ﹤0.01%
26,104

Similar funds

RhumbLine Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.

  • RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
  • RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
  • RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
  • RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
  • RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
  • RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.